What's new

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 32, Status: Authorised

May 8, 2025 - 11:02
 0
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 32, Status: Authorised
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 32, Status: Authorised
Read More

Tags:

Previous Article

American Express Reveals the Top Trends Shaping Luxury Travel

Next Article

Human medicines European public assessment report (EPAR): Tremfya, guselkumab, D...

Related Posts

Human medicines European public assessment report (EPAR): Denosumab BBL, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 55, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

Human medicines European public assessment report (EPAR): Enwylma, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0